Conducted an independent $420M valuation and strategic positioning exercise ahead of a planned public listing on a major European exchange.
MedGroup needed an independent, institutional-grade valuation that would withstand scrutiny from public market investors, while also articulating a compelling equity story that differentiated it from listed peers.
We performed a multi-methodology valuation combining DCF, comparable company analysis, and precedent transactions. Simultaneously, we developed the strategic narrative, identified value creation levers, and stress‑tested assumptions against investor expectations.
Strathaus understood both the numbers and the narrative. Their valuation work gave us credibility with institutional investors, and their strategic framing helped us tell a differentiated story.— CFO, MedGroup International